Rx Propellant Profile
Key Indicators
- Authorised Capital ₹ 240.01 Cr
as on 29-10-2024
- Paid Up Capital ₹ 99.01 Cr
as on 29-10-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -61900.73%
(FY 2023)
- Ebitda -71094.20%
(FY 2023)
- Net Worth 117903.27%
(FY 2023)
- Total Assets 226694.73%
(FY 2023)
About Rx Propellant
The Corporate was formerly known as Rx Propellant Asset Advisors Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 240.01 Cr and a paid-up capital of Rs 99.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Rx Propellant Private Limited India are Mohammed Farouqui as Company Secretary, Sandhya Sama as Cfo, and Milind Ravi as Ceo. Jasmeet Chhabra, Ashish Singh, Vishal Goel, and Five other members serve as directors at the Company.
- CIN/LLPIN
U70109TG2020PTC145191
- Company No.
145191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2020
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Rx Propellant?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Goel  | Managing Director | 11-May-2022 | Current |
| Mohammed Farouqui | Company Secretary | 02-Aug-2022 | Current |
| Sandhya Sama | CFO | 06-Jun-2022 | Current |
| Milind Ravi | CEO | 11-May-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jasmeet Chhabra | Director | Current | |
| Ashish Singh | Director | 11-May-2022 | Current |
| Dinesh Meel | Director | 14-May-2024 | Current |
Brian Chinappi  | Director | Current | |
| Raghvendra Chandak | Director | 11-May-2022 | Current |
| Praveen Sridharan | Director | 11-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Rx Propellant.
Rx Propellant Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 61900.73% decrease in profit. The company's net worth Soared by an impressive increase of 117903.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rx Propellant?
In 2023, Rx Propellant had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Crimson Education Management Services Private LimitedActive 4 years 11 monthsJasmeet Chhabra and Vishal Goel are mutual person
Gv Discovery Centers Private LimitedActive 6 years 2 monthsAshish Singh, Raghvendra Chandak and 1 more are mutual person
Mahindra Homes Private LimitedActive 14 years 6 monthsAshish Singh and Raghvendra Chandak are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rx Propellant?
Rx Propellant has a workforce of 24 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rx Propellant, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx Propellant's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
